69037
Ureidosuccinic acid
98.0-102.0% (T)
Sinonimo/i:
N-Carbamoyl-DL-aspartic acid
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Taglio della confezione | SKU | Disponibilità | Prezzo |
|---|---|---|---|
| 100 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 880.00 | |
| 500 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 1’700.00 |
Informazioni su questo articolo
Formula condensata:
HOOCCH2CH(NHCONH2)COOH
Numero CAS:
Peso molecolare:
176.13
UNSPSC Code:
12352106
NACRES:
NA.25
PubChem Substance ID:
EC Number:
213-096-6
Beilstein/REAXYS Number:
1726861
MDL number:
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiQuality Level
assay
98.0-102.0% (T)
mp
~175 °C (dec.)
format
neat
SMILES string
NC(=O)NC(CC(O)=O)C(O)=O
InChI
1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)
InChI key
HLKXYZVTANABHZ-UHFFFAOYSA-N
Biochem/physiol Actions
Metabolite of pyrimidine biosynthesis, alanine, aspartate and glutamate metabolism.
1 of 1
Questo articolo | |||
|---|---|---|---|
| format neat | format - | format - | format - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 200 |
| assay 98.0-102.0% (T) | assay ≥98.0% (T) | assay ≥99.0% | assay 88.0-92.0% |
| mp ~175 °C (dec.) | mp 170-175 °C (dec.) | mp 195-210 °C (dec.) | mp - |
Classe di stoccaggio
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
André B P van Kuilenburg et al.
Clinical chemistry, 50(11), 2117-2124 (2004-09-18)
The concentrations of the pyrimidine "de novo" metabolites and their degradation products in urine are useful indicators for the diagnosis of an inborn error of the pyrimidine de novo pathway or a urea-cycle defect. Until now, no procedure was available
L D Fairbanks et al.
Journal of chromatography. B, Biomedical sciences and applications, 732(2), 487-493 (1999-10-12)
Leflunomide is an immunomodulatory drug which acts by inhibiting dihydroorotic acid dehydrogenase, the fourth enzyme of pyrimidine biosynthesis. We modified our high-performance liquid chromatography method to demonstrate that the principal metabolite in mitogen-stimulated human T-lymphocytes incubated with leflunomide was not
Amy J Rice et al.
Analytical biochemistry, 441(1), 87-94 (2013-06-19)
Dihydroorotase (DHOase) is the third enzyme in the de novo pyrimidine biosynthesis pathway and is a potential new antibacterial drug target. No target-based high-throughput screening (HTS) assay for this enzyme has been reported to date. Here, we optimized two colorimetric-based
Numero articolo commerciale globale
| SKU | GTIN |
|---|---|
| 69037-100MG | 04061832404912 |
| 69037-500MG | 04061832404929 |